Tandem Diabetes Care (TNDM) Share-based Compensation (QoQ) (2013 - 2025)
Tandem Diabetes Care (TNDM) Share-based Compensation (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -197.35% |
| Jun 30, 2025 | 0.60% |
| Mar 31, 2025 | -72.40% |
| Dec 31, 2024 | 343.64% |
| Sep 30, 2024 | -184.91% |
| Jun 30, 2024 | 1,846.03% |
| Mar 31, 2024 | -97.40% |
| Dec 31, 2023 | 297.51% |
| Sep 30, 2023 | -290.57% |
| Jun 30, 2023 | 10.41% |
| Mar 31, 2023 | -13.29% |
| Dec 31, 2022 | 148.84% |
| Sep 30, 2022 | -154.15% |
| Jun 30, 2022 | 410.24% |
| Mar 31, 2022 | -60.34% |
| Dec 31, 2021 | 455.73% |
| Sep 30, 2021 | -185.71% |
| Jun 30, 2021 | 15.68% |
| Sep 30, 2020 | 131.40% |
| Jun 30, 2020 | -144.50% |